For example, the circ-E-Cad-encoded SEP promotes glioma progression via EGFR-STAT3 pathway activation (27), while the SEP encoded by the lncRNA FOXD1-AS1 serves as a glioma-specific biomarker and holds potential as a therapeutic target (28). This evidence concerns the gene FOXD1 and central nervous system cancer.